Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04700540
Other study ID # STUDY00006318
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date April 1, 2024

Study information

Verified date April 2024
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The researchers propose to develop an informatics system to assist people with memory impairment. Persons with Memory Concern (PWMC) recognize the faces they see daily, such as a spouse or caregiver, but they may confuse visiting friends and grandchildren or they may not match names with faces well. The inability to remember names or relationships contributes to isolation and deeply affects their social lives. The proposed solution is a Smartwatch Reminder (SR) system to conspicuously provide this information to the PWMC when needed. The system will be evaluated on the target persons with memory concern population to measure engagement and improvements in social interactions and quality of life.


Description:

This research will evaluate technology designed to improve the quality of life for persons with dementia through external aids to assist with remembering. The primary goal of the Smartwatch Reminder (SR) is to facilitate social interaction for Persons with Memory Concern (PWMC) by providing facial recognition of family, friends, and other key people. The SR will be evaluated using an embedded experimental mixed methods design that combines the collection and analysis of qualitative data within a traditional randomized controlled trial design. To do so, researchers will enroll 100 PWMC and their care partners to participate in initial, 3-month, and 6-month surveys. Half of the PWMCs will be randomly assigned to the intervention group (i.e. receive the SR) and the other half randomly assigned to the attention control group. Each participant will take part in the study for a total of 6 months. All study procedures and data analysis are anticipated to be completed within 24 months.


Recruitment information / eligibility

Status Completed
Enrollment 162
Est. completion date April 1, 2024
Est. primary completion date April 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion criteria for PWMC are as follows: - English speaking - a physician diagnosis of early-stage Alzheimer's disease or mild-to-moderate cognitive impairment - no history of serious mental illness (i.e., any major psychiatric disorder) Inclusion criteria for care partners of PWMC are as follows: - English speaking - 21 years of age or over - self-identifies as someone who provides assistance to the PWMC because of their memory loss (these individuals are called ''care partners,'' as these individuals may or may not provide the intensive hands-on care typical of ''caregivers'') - plans to remain in the area for at least 6 months in order to reduce loss to follow-up - indicates a willingness to use the smartwatch system Exclusion Criteria for PWMC are as follows: - non-English speaking - no physician diagnosis of early-stage Alzheimer's disease or mild-to-moderate cognitive impairment - a history of serious mental illness (i.e., any major psychiatric disorder) Exclusion criteria for care partners of PWMC are as follows: - non-English speaking - under 21 years of age - does not identify as someone who provides assistance to the PWMC because of their memory loss - does not plan on remaining in the area for at least 6 months - does not indicate a willingness to use the smartwatch system

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Smartwatch Reminder (SR) system
The Smartwatch Reminder (SR) system will automatically transmit pictures and relevant information, such as name or relationship, to a smartwatch worn by the PWMC when family or friends visit.

Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (4)

Lead Sponsor Collaborator
University of Minnesota Advanced Medical Electronics, Brown University, University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in PWMC Social Interaction Frequency 8-item measure of the frequency of the PWMC's social interactions Baseline, 3-, and 6-months
Primary Change in PWMC Social Interaction Quality 8-item measure of the quality of the PWMC's social interactions (scores range from 8 to 40; higher scores suggest greater satisfaction with social interactions) Baseline, 3-, and 6-months
Primary Change in PWMC Quality of Life 21-item adapted Dementia Quality of Life (DQoL) measure (scores range from 0 to 105; higher scores indicate higher quality of life) Baseline, 3-, and 6-months
Secondary Change in Care Partner Psychosocial Well-Being 11-item Eriksonian Psychosocial Stage Inventory (scores range from 11 to 55; higher scores suggest greater well-being) Baseline, 3-, and 6-months
Secondary Change in Care Partner Depression 10-item Center for Epidemiological Studies - Depression Scale (scores range from 0 to 30; higher scores suggest more severe depression symptoms) Baseline, 3-, and 6-months
Secondary Change in Social Support 8-item scale to assess affective assistance by care partner's social network (scores range from 8 to 40; higher scores suggest higher affective assistance by social network) Baseline, 3-, and 6-months
Secondary Change in Social Engagement 6-item Lubben Social Network Scale (LSNS-6) (scores range from 0 to 30; higher scores suggest higher risk of social isolation) Baseline, 3-, and 6-months
Secondary Change in Negative Health Transitions 1-item to assess change in living or care situation and mortality Baseline, 3-, and 6-months
Secondary Change in Relationship Quality 6-item version of the Relationship Assessment Scale (scores range from 0 to 30; higher scores suggest higher satisfaction with the relationship) Baseline, 3-, and 6-months
Secondary Change in Pleasant Events Schedule 20-items adapted measure of events and activities (PES-AD) (scores range from 0 to 60; higher scores suggest greater enjoyment with events and activities) Baseline, 3-, and 6-months
Secondary Change in Community Engagement 15-item survey developed to evaluate the PWMC's typical social interactions and destinations accessed outside of the home (scores range from 0 to 75; higher scores indicate greater community engagement) Baseline, 3-, and 6-months
Secondary Change in PWMC Functional Status 12-item survey to assess Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) (scores range from 0 to 36; higher scores indicate greater impairment in function) Baseline, 3-, and 6-months
Secondary Change in Memory Impairment 8-item survey to evaluate level of memory impairment of PWMC (scores range from 8 to 40; higher scores indicate greater memory impairment) Baseline, 3-, and 6-months
Secondary Change in Care Partner Reactions to Memory and Behavioral Problems 24-item Revised Memory and Behavior Problem Checklist (scores range from 0 to 96; higher scores indicate greater distress associated with problems) Baseline, 3-, and 6-months
Secondary Change in Care Partner Quality of Life Ladder Cantril's Ladder (scores range from 0 to 10; higher scores suggest higher quality of life) Baseline, 3-, and 6-months
Secondary Change in Care Partner Loneliness in Relationship UCLA Loneliness Scale (scores range from 20 to 80; higher scores indicate greater loneliness) Baseline, 3-, and 6-months
See also
  Status Clinical Trial Phase
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A